Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest update is out from iSpecimen ( (ISPC) ).
iSpecimen Inc. convened its 2025 Annual Meeting of Stockholders on December 31, 2025, but the meeting was adjourned twice—first on December 31 and again when reconvened on January 23, 2026—because the company failed to achieve a quorum of shareholders. The company now plans to reconvene the delayed 2025 Annual Meeting on February 13, 2026, with the record date remaining November 3, 2025, highlighting ongoing challenges in securing sufficient shareholder participation to vote on proxy proposals and finalize annual governance matters.
The most recent analyst rating on (ISPC) stock is a Hold with a $0.31 price target. To see the full list of analyst forecasts on iSpecimen stock, see the ISPC Stock Forecast page.
Spark’s Take on ISPC Stock
According to Spark, TipRanks’ AI Analyst, ISPC is a Neutral.
The score is held down primarily by weak financial performance—sharp TTM revenue decline, significantly lower gross margin, continuing losses, and persistent cash burn. Technicals remain broadly bearish with the stock below key longer-term moving averages and a negative MACD, while valuation offers little support given the negative P/E and no dividend yield data. Corporate events provide some offset via regained Nasdaq equity compliance and financing/compliance actions, but the bid-price delisting notice remains a meaningful risk.
To see Spark’s full report on ISPC stock, click here.
More about iSpecimen
Average Trading Volume: 1,161,699
Technical Sentiment Signal: Strong Sell
Current Market Cap: $3.67M
Learn more about ISPC stock on TipRanks’ Stock Analysis page.